Lysine
In clinical developmentAlso known as (S)-lysine, 6-ammonio-L-norleucine, Aminosyn 10%, Sulfite-Free, Aminosyn 3.5 % M, Sulfite Free+45 more
(S)-lysine, 6-ammonio-L-norleucine, Aminosyn 10%, Sulfite-Free, Aminosyn 3.5 % M, Sulfite Free, Aminosyn 8.5 % with Electrolytes, Sulfite-Free, Aminosyn 8.5%, Sulfite-Free, Aminosyn II 10 %, Aminosyn II 15%, Aminosyn II 8.5 % with Electrolytes, Sulfite-Free, Aminosyn II 8.5 %, Sulfite-Free, Aminosyn-HBC 7 %, Sulfite-Free, Aminosyn-PF 10 %, Sulfite-Free, Aminosyn-PF 7%, Clinisol 15, Freamine III 10, Hepatamine 8, Hepatasol, L-Formula, L-Lysin, L-Lysine, L-lys, LYS, Lysine acid, Nephramine, Plenamine, PremaSol, ProSol, ProcalAmine 3, Travasol 10, Travasol 10%, Trophamine, Trophamine 10 %, Trophamine 6 %, Lysina, (S)-2,6-diaminohexanoic acid, Clinimix 4.25/10, Clinimix 4.25/25, Clinimix 4.25/5, Clinimix 5/15, Clinimix 5/20, Clinimix 5/25, Clinimix E 2.75/5, Clinimix E 4.25/10, Clinimix E 4.25/5, Clinimix E 5/15, Clinimix E 5/20, Clinimix E 5/25, L-2,6-Diaminocaproic acid, Lysinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3
Histone lactylation: from tumor lactate metabolism to epigenetic regulation.
N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson's disease.
Human neocortical expansion involves glutamatergic neuron diversification.
The Effect of Acute Lysine Administration on α-aminoadipic Acid
An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia
Hippocampal CA1 interneurons: an in vivo intracellular labeling study.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Aging cell1
- Autophagy1
- International journal of biological sciences1
- Nature1
- Nature communications1
- The Journal of neuroscience : the official journal of the Society for Neuroscience1
- Shi S2
- Zhang Z2
- Alfiler L1
- Alva AS1
- Anastassiou C1
- Arkhipov A1
- Baker K1
- Bakken TE1
- Allen Institute for Brain Science1
- Brigham and Women's Hospital/Dana-Farber Cancer Institute1
- Cancer Center Amsterdam1
- Center for Molecular and Behavioral Neuroscience1
- Center for Neurogenomics and Cognitive Research (CNCR)1
- CHU de Quebec and Laval University1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Lysine in the shared literature.
Studied across 2 of the same disease areas as Lysine in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials